BioCentury | Apr 6, 2019
Finance

Everybody up

...Holdings Ltd. (HKSE:950) Solasia Pharma K.K. (Tokyo:4597) Licensed from Camaros AB (SSE:CAMX) China's NMPA approved Episil...
BioCentury | Feb 22, 2019
Company News

China approves Solasia's oral mucositis product

...Solasia Pharma K.K. (Tokyo:4597) said China's National Medical Products Administration approved Episil (SP-03) to relieve pain...
...relieve pain associated with oral mucositis. The company added ¥50 (31%) to ¥210 on Thursday. Episil...
...Camurus was off SEK2 to SEK67.30 on Thursday. Lee's added HK$0.05 to HK$6.46. Hongjiang Li episil (SP-03, episil oral spray) Camurus...
BioCentury | Feb 22, 2019
Clinical News

China approves Solasia's oral mucositis product

...Solasia Pharma K.K. (Tokyo:4597) said China's National Medical Products Administration approved Episil (SP-03) to relieve pain...
...pain associated with oral mucositis. The company added ¥50 (31%) to ¥210 on Feb. 21. Episil...
...Kong, China Solasia Pharma K.K. (Tokyo:4597), Tokyo, Japan Product: Episil (SP-03) Business: Neurology Hongjiang Li episil (SP-03, episil oral spray) Camurus...
BioCentury | May 18, 2018
Company News

Meiji launches Episil in Japan

...Meiji Seika Pharma Co. Ltd. (Tokyo, Japan) launched episil (SP-3) in Japan to treat pain associated...
...K.K. (Tokyo:4597), Tokyo, Japan Meiji Seika Pharma Co. Ltd., Tokyo, Japan Business: Neurology Shannon Lehnbeuter episil (SP-03, episil oral spray) Camurus...
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

The miserable performance of large cap biotechs last quarter is likely to be a boon for small- and mid-cap players this year, in more ways than one. Buysiders spent most of 2017 focusing to a...
BioCentury | Oct 6, 2017
Finance

Bargain shopping

...with an adjuvant treatment regimen which includes Herceptin trastuzumab Solasia Pharma K.K. (Tokyo:4597) Japan approves Episil...
BioCentury | Aug 4, 2017
Clinical News

Japan approves Solasia's Episil

...Solasia Pharma K.K. (Tokyo:4597) said Japan's Ministry of Health, Labour and Welfare (MHLW) approved Episil (episil oral spray...
...cancer patients. Solasia's partner Meiji Seika Pharma Co. Ltd. (Tokyo, Japan) has Japanese rights to Episil...
...Seika Pharma Co. Ltd. , Tokyo, Japan Product: Episil ( episil oral spray , SP-03) Business: Neurology Alicia Parker episil Camurus...
BioCentury | Jul 7, 2017
Company News

Japan approves Episil

...Solasia Pharma K.K. (Tokyo:4597) said Japan's Ministry of Health, Labour and Welfare (MHLW) approved Episil (SP-03...
...cancer patients. Solasia's partner Meiji Seika Pharma Co. Ltd. (Tokyo, Japan) has Japanese rights to Episil...
...FluidCrystal film. It is marketed in the U.S. and Europe. Solasia has exclusive rights to Episil...
BioCentury | Mar 25, 2017
Finance

Solasia goes to market

...a lipid-based liquid that transforms into a bioadhesive FluidCrystal film. It is marketed as Episil oral spray...
BioCentury | Jul 9, 2012
Company News

Camurus, Sinclair IS Pharma, Teva sales and marketing update

...commercialization rights in Europe for Episil oral spray to Camurus. Sinclair, which gained European commercialization rights for Episil...
...rights that it sublicensed to Teva under a 2011 deal. Teva has rights to commercialize Episil...
...the return but that it will incur a non-cash impairment charge of £950,000 ($1.5 million). Episil...
Items per page:
1 - 10 of 12